OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Polypharmacy in Chronic Neurological Diseases: Multiple Sclerosis, Dementia and Parkinson’s Disease
Niklas Frahm, Michael Hecker, Uwe K. Zettl
Current Pharmaceutical Design (2021) Vol. 27, Iss. 38, pp. 4008-4016
Closed Access | Times Cited: 18
Niklas Frahm, Michael Hecker, Uwe K. Zettl
Current Pharmaceutical Design (2021) Vol. 27, Iss. 38, pp. 4008-4016
Closed Access | Times Cited: 18
Showing 18 citing articles:
Comorbidity among inpatients with dementia: a preliminary cross-sectional study in West China
Xiaoqiang Xiao, Shunju Xiang, Qingya Xu, et al.
Aging Clinical and Experimental Research (2023) Vol. 35, Iss. 3, pp. 659-667
Open Access | Times Cited: 11
Xiaoqiang Xiao, Shunju Xiang, Qingya Xu, et al.
Aging Clinical and Experimental Research (2023) Vol. 35, Iss. 3, pp. 659-667
Open Access | Times Cited: 11
„Demenz Care“ in der SAPV – Handlungsempfehlung für die Verordnung von SAPV
Monika Fuchs, Sebastian Schiel
Zeitschrift für Palliativmedizin (2025) Vol. 26, Iss. 01, pp. 31-36
Closed Access
Monika Fuchs, Sebastian Schiel
Zeitschrift für Palliativmedizin (2025) Vol. 26, Iss. 01, pp. 31-36
Closed Access
Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
Paula Bachmann, Niklas Frahm, Jane Louisa Debus, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 592-592
Open Access | Times Cited: 14
Paula Bachmann, Niklas Frahm, Jane Louisa Debus, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 592-592
Open Access | Times Cited: 14
Metformin Adherence Reduces the Risk of Dementia in Patients With Diabetes: A Population-based Cohort Study
Po‐Chih Chen, Chien‐Tai Hong, Wan‐Ting Chen, et al.
Endocrine Practice (2023) Vol. 29, Iss. 4, pp. 247-253
Closed Access | Times Cited: 7
Po‐Chih Chen, Chien‐Tai Hong, Wan‐Ting Chen, et al.
Endocrine Practice (2023) Vol. 29, Iss. 4, pp. 247-253
Closed Access | Times Cited: 7
Oral health in patients with neurodegenerative and cerebrovascular disease: a retrospective study
Marc Auerbacher, Lydia Gebetsberger, Dalia Kaisarly, et al.
Disability and Rehabilitation (2022) Vol. 45, Iss. 14, pp. 2316-2324
Closed Access | Times Cited: 12
Marc Auerbacher, Lydia Gebetsberger, Dalia Kaisarly, et al.
Disability and Rehabilitation (2022) Vol. 45, Iss. 14, pp. 2316-2324
Closed Access | Times Cited: 12
Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis
Michael Hecker, Niklas Frahm, Uwe K. Zettl
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 3-3
Open Access | Times Cited: 6
Michael Hecker, Niklas Frahm, Uwe K. Zettl
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 3-3
Open Access | Times Cited: 6
Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis
Jane Louisa Debus, Paula Bachmann, Niklas Frahm, et al.
Therapeutic Advances in Chronic Disease (2022) Vol. 13, pp. 204062232211083-204062232211083
Open Access | Times Cited: 10
Jane Louisa Debus, Paula Bachmann, Niklas Frahm, et al.
Therapeutic Advances in Chronic Disease (2022) Vol. 13, pp. 204062232211083-204062232211083
Open Access | Times Cited: 10
Polypharmacy in Multiple Sclerosis: Prevalence, Risks, and Mitigation Strategies
W. Chapman, Megan C. Herink, Michelle Cameron, et al.
Current Neurology and Neuroscience Reports (2023) Vol. 23, Iss. 9, pp. 521-529
Closed Access | Times Cited: 4
W. Chapman, Megan C. Herink, Michelle Cameron, et al.
Current Neurology and Neuroscience Reports (2023) Vol. 23, Iss. 9, pp. 521-529
Closed Access | Times Cited: 4
Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis
Julia Baldt, Niklas Frahm, Michael Hecker, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 16, pp. 5379-5379
Open Access | Times Cited: 4
Julia Baldt, Niklas Frahm, Michael Hecker, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 16, pp. 5379-5379
Open Access | Times Cited: 4
Potential adverse events associated with sphingosine-1-phosphate (S1P) receptor modulators in patients with multiple sclerosis: an analysis of the FDA adverse event reporting system (FAERS) database
Xiping Yang, Yan Yan, Suyao Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Xiping Yang, Yan Yan, Suyao Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Treatment patterns in pediatric patients with multiple sclerosis in Germany—a nationwide claim-based analysis
Niklas Frahm, Melanie Peters, Jörg Bätzing, et al.
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 9
Niklas Frahm, Melanie Peters, Jörg Bätzing, et al.
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 9
Current Pharmaceutical Trends in Neuroimmunology - Part I: Disorders Affecting the CNS
Paulus Rommer, Uwe K. Zettl
Current Pharmaceutical Design (2022) Vol. 28, Iss. 6, pp. 427-427
Closed Access | Times Cited: 5
Paulus Rommer, Uwe K. Zettl
Current Pharmaceutical Design (2022) Vol. 28, Iss. 6, pp. 427-427
Closed Access | Times Cited: 5
Effectiveness of Technology-Assisted Medication Reminder Systems in Neurodegenerative Diseases: Systematic Review and Meta-analysis
Kevin C. Tseng, Yihan Wang
Lecture notes in computer science (2024), pp. 345-360
Closed Access
Kevin C. Tseng, Yihan Wang
Lecture notes in computer science (2024), pp. 345-360
Closed Access
Personality traits in patients with multiple sclerosis: their association with nicotine dependence and polypharmacy
Janina Meißner, Niklas Frahm, Michael Hecker, et al.
Therapeutic Advances in Neurological Disorders (2024) Vol. 17
Open Access
Janina Meißner, Niklas Frahm, Michael Hecker, et al.
Therapeutic Advances in Neurological Disorders (2024) Vol. 17
Open Access
Literaturverzeichnis zum Titel: Zettl/Sieb: Diagnostik und Therapie neurologischer Erkrankungen, 6.A. 2024
Elsevier eBooks (2024), pp. e1-e123
Closed Access
Elsevier eBooks (2024), pp. e1-e123
Closed Access
Polypharmazie
Niklas Frahm, Michael Hecker, Uwe K. Zettl
Elsevier eBooks (2024), pp. 659-667
Closed Access
Niklas Frahm, Michael Hecker, Uwe K. Zettl
Elsevier eBooks (2024), pp. 659-667
Closed Access
Profile of Patients attending the Neuropsychiatric Specialty Clinic of a Tertiary Care Teaching Hospital in North India: A Retrospective Chart Review
Sujita Kumar Kar, Aathira J Prakash, PK Dalal
Indian Journal of Behavioural Sciences (2023) Vol. 26, Iss. 01, pp. 31-37
Open Access
Sujita Kumar Kar, Aathira J Prakash, PK Dalal
Indian Journal of Behavioural Sciences (2023) Vol. 26, Iss. 01, pp. 31-37
Open Access
A Comprehensive Review of the Neuroprotective Effects of Saffron (Crocus Sativus) and its Constituents in Parkinson's Disease
Alireza Hoseini, Amirhossein Heidari, Ali Shoeibi, et al.
(2023)
Closed Access
Alireza Hoseini, Amirhossein Heidari, Ali Shoeibi, et al.
(2023)
Closed Access
